Ratchet effect

Last updated

A mechanical ratchet moving in its "forward" direction and unable to move backward. Ratchet example.gif
A mechanical ratchet moving in its "forward" direction and unable to move backward.

A ratchet effect is an instance of the restrained ability of human processes to be reversed once a specific thing has happened, analogous with the mechanical ratchet that holds the spring tight as a clock is wound up. It is related to the phenomena of featuritis and scope creep in the manufacture of various consumer goods, and of mission creep in military planning.

Contents

In sociology, "ratchet effects refer to the tendency for central controllers to base next year's targets on last year's performance, meaning that managers who expect still to be in place in the next target period have a perverse incentive not to exceed targets even if they could easily do so". [1]

Examples

Famine cycle

Garrett Hardin, a biologist and environmentalist, used the phrase to describe how food aid keeps people alive who would otherwise die in a famine. They live and multiply in better times, making another bigger crisis inevitable, since the supply of food has not been increased. [2]

The ratchet effect first came to light in Alan Peacock and Jack Wiseman's work, The Growth of Public Expenditure in the United Kingdom. Peacock and Wiseman found that public spending increases like a ratchet following periods of crisis. [3] The term was later used by American historian Robert Higgs to highlight Peacock and Wiseman's research in his book, "Crisis and Leviathan". [4] Similarly, governments have difficulty in rolling back huge bureaucratic organizations created initially for temporary needs, e.g., at times of war, natural or economic crisis. [5] The effect may likewise afflict large business corporations with myriad layers of bureaucracy which resist reform or dismantling.[ citation needed ]

Production strategy

Jean Tirole used the concept in his pioneering work on regulation and monopolies. The ratchet effect can denote an economic strategy arising in an environment where incentive depends on both current and past production, such as in a competitive industry employing piece rates. The producers observe that since incentive is readjusted based on their production, any increase in production confers only a temporary increase in incentive while requiring a permanently greater expenditure of work. They therefore decide not to reveal hidden production capacity unless forced to do so.

Game theory

The ratchet effect is central to the mathematical Parrondo's paradox.

Cultural anthropology

In 1999 comparative psychologist Michael Tomasello used the ratchet effect metaphor to shed light on the evolution of culture. [6] He explains that the sharedness of human culture means that it is cumulative in character. Once a certain invention has been made, it can jump from one mind to another (by means of imitation) and thus a whole population can acquire a new trait (and so the ratchet has gone "up" one tooth). Comparative psychologist Claudio Tennie, Tomasello, and Josep Call call this the "cultural ratchet" and they describe it, amongst primates, as being unique to human culture. [7]

Developmental biology

Receptors which initiate cell fate transduction cascades, in early embryo development, exhibit a ratchet effect in response to morphogen concentrations. [8] The low receptor occupancy permits increases in receptor occupancy which alter the cell fate, but the high receptor affinity does not allow ligand dissociation leading to a cell fate of a lower concentration.

Technology regulation

The ratchet effect is reflected in the Collingridge dilemma.

Application in economics

Consumer products

The ratchet effect can be seen in long-term trends in the production of many consumer goods. Year by year, automobiles gradually acquire more features. Competitive pressures make it hard for manufacturers to cut back on the features unless forced by a true scarcity of raw materials (e.g., an oil shortage that drives costs up radically). University textbook publishers gradually get "stuck" in producing books that have excess content and features.

In software development, products which compete often will use specification lists of competitive products to add features, presuming that they must provide all of the features of the competitive product, plus add additional functionality. This can lead to "feature creep" in which it is considered necessary to add all of a competitor's features whether or not customers will use them.

Airlines initiate frequent-flyer programs that become ever harder to terminate. Successive generations of home appliances gradually acquire more features; new editions of software acquire more features; and so on. With all of these goods, there is ongoing debate as to whether the added features truly improve usability, or simply increase the tendency for people to buy the goods.

Trade legislation

The term was included by the MAI Negotiating Group in the 1990s as the essence of a device to enforce legislative progress toward "free trade" by preventing legislative rollback with the compulsory assent of governments as a condition of participation.

Rollback is the liberalisation process by which the reduction and eventual elimination of nonconforming measures to the MAI would take place. It is a dynamic element linked with standstill, which provides its starting point. Combined with standstill, it would produce a "ratchet effect", where any new liberalisation measures would be "locked in" so they could not be rescinded or nullified over time. [9]

See also

Related Research Articles

<span class="mw-page-title-main">Hormone</span> Biological signalling molecule

A hormone is a class of signaling molecules in multicellular organisms that are sent to distant organs by complex biological processes to regulate physiology and behavior. Hormones are required for the correct development of animals, plants and fungi. Due to the broad definition of a hormone, numerous kinds of molecules can be classified as hormones. Among the substances that can be considered hormones, are eicosanoids, steroids, amino acid derivatives, protein or peptides, and gases.

<span class="mw-page-title-main">Neurotransmitter</span> Chemical substance that enables neurotransmission

A neurotransmitter is a signaling molecule secreted by a neuron to affect another cell across a synapse. The cell receiving the signal, or target cell, may be another neuron, but could also be a gland or muscle cell.

<span class="mw-page-title-main">Acetylcholine</span> Organic chemical and neurotransmitter

Acetylcholine (ACh) is an organic compound that functions in the brain and body of many types of animals as a neurotransmitter. Its name is derived from its chemical structure: it is an ester of acetic acid and choline. Parts in the body that use or are affected by acetylcholine are referred to as cholinergic.

<span class="mw-page-title-main">Natural killer cell</span> Type of cytotoxic lymphocyte

Natural killer cells, also known as NK cells or large granular lymphocytes (LGL), are a type of cytotoxic lymphocyte critical to the innate immune system that belong to the rapidly expanding family of known innate lymphoid cells (ILC) and represent 5–20% of all circulating lymphocytes in humans. The role of NK cells is analogous to that of cytotoxic T cells in the vertebrate adaptive immune response. NK cells provide rapid responses to virus-infected cell and other intracellular pathogens acting at around 3 days after infection, and respond to tumor formation. Typically, immune cells detect the antigen presented on major histocompatibility complex (MHC) on infected cell surfaces, triggering cytokine release, causing the death of the infected cell by lysis or apoptosis. NK cells are unique, however, as they have the ability to recognize and kill stressed cells in the absence of antibodies and MHC, allowing for a much faster immune reaction. They were named "natural killers" because of the notion that they do not require activation to kill cells that are missing "self" markers of MHC class I. This role is especially important because harmful cells that are missing MHC I markers cannot be detected and destroyed by other immune cells, such as T lymphocyte cells.

<span class="mw-page-title-main">Glucocorticoid</span> Class of corticosteroids

Glucocorticoids are a class of corticosteroids, which are a class of steroid hormones. Glucocorticoids are corticosteroids that bind to the glucocorticoid receptor that is present in almost every vertebrate animal cell. The name "glucocorticoid" is a portmanteau and is composed from its role in regulation of glucose metabolism, synthesis in the adrenal cortex, and its steroidal structure.

<span class="mw-page-title-main">Receptor (biochemistry)</span> Protein molecule receiving signals for a cell

In biochemistry and pharmacology, receptors are chemical structures, composed of protein, that receive and transduce signals that may be integrated into biological systems. These signals are typically chemical messengers which bind to a receptor and produce physiological responses such as change in the electrical activity of a cell. For example, GABA, an inhibitory neurotransmitter inhibits electrical activity of neurons by binding to GABAA receptors. There are three main ways the action of the receptor can be classified: relay of signal, amplification, or integration. Relaying sends the signal onward, amplification increases the effect of a single ligand, and integration allows the signal to be incorporated into another biochemical pathway.

<span class="mw-page-title-main">Receptor antagonist</span> Type of receptor ligand or drug that blocks a biological response

A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist. Antagonist drugs interfere in the natural operation of receptor proteins. They are sometimes called blockers; examples include alpha blockers, beta blockers, and calcium channel blockers. In pharmacology, antagonists have affinity but no efficacy for their cognate receptors, and binding will disrupt the interaction and inhibit the function of an agonist or inverse agonist at receptors. Antagonists mediate their effects by binding to the active site or to the allosteric site on a receptor, or they may interact at unique binding sites not normally involved in the biological regulation of the receptor's activity. Antagonist activity may be reversible or irreversible depending on the longevity of the antagonist–receptor complex, which, in turn, depends on the nature of antagonist–receptor binding. The majority of drug antagonists achieve their potency by competing with endogenous ligands or substrates at structurally defined binding sites on receptors.

<span class="mw-page-title-main">Pharmacodynamics</span> Area of Academic Study

Pharmacodynamics (PD) is the study of the biochemical and physiologic effects of drugs. The effects can include those manifested within animals, microorganisms, or combinations of organisms.

<span class="mw-page-title-main">Adenosine receptor</span> Class of four receptor proteins to the molecule adenosine

The adenosine receptors (or P1 receptors) are a class of purinergic G protein-coupled receptors with adenosine as the endogenous ligand. There are four known types of adenosine receptors in humans: A1, A2A, A2B and A3; each is encoded by a different gene.

<span class="mw-page-title-main">Betaxolol</span> Chemical compound

Betaxolol is a selective beta1 receptor blocker used in the treatment of hypertension and angina. Being selective for beta1 receptors, it typically has fewer systemic side effects than non-selective beta-blockers, for example, not causing bronchospasm as timolol may. Betaxolol also shows greater affinity for beta1 receptors than metoprolol. In addition to its effect on the heart, betaxolol reduces the pressure within the eye. This effect is thought to be caused by reducing the production of the liquid within the eye. The precise mechanism of this effect is not known. The reduction in intraocular pressure reduces the risk of damage to the optic nerve and loss of vision in patients with elevated intraocular pressure due to glaucoma.

<span class="mw-page-title-main">Aminophylline</span> Chemical compound

Aminophylline is a compound of the bronchodilator theophylline with ethylenediamine in 2:1 ratio. The ethylenediamine improves solubility, and the aminophylline is usually found as a dihydrate.

A co-receptor is a cell surface receptor that binds a signalling molecule in addition to a primary receptor in order to facilitate ligand recognition and initiate biological processes, such as entry of a pathogen into a host cell.

<span class="mw-page-title-main">Interleukin 13</span> Protein and coding gene in humans

Interleukin 13 (IL-13) is a protein that in humans is encoded by the IL13 gene. IL-13 was first cloned in 1993 and is located on chromosome 5q31.1 with a length of 1.4kb. It has a mass of 13 kDa and folds into 4 alpha helical bundles. The secondary structural features of IL-13 are similar to that of Interleukin 4 (IL-4); however it only has 25% sequence identity to IL-4 and is capable of IL-4 independent signaling. IL-13 is a cytokine secreted by T helper type 2 (Th2) cells, CD4 cells, natural killer T cell, mast cells, basophils, eosinophils and nuocytes. Interleukin-13 is a central regulator in IgE synthesis, goblet cell hyperplasia, mucus hypersecretion, airway hyperresponsiveness, fibrosis and chitinase up-regulation. It is a mediator of allergic inflammation and different diseases including asthma.

<span class="mw-page-title-main">Tetramethylenedisulfotetramine</span> Chemical compound

Tetramethylenedisulfotetramine (TETS) is an organic compound used as a rodenticide. It is an odorless, tasteless white powder that is slightly soluble in water, DMSO and acetone, and insoluble in methanol and ethanol. It is a sulfamide derivative. It can be synthesized by reacting sulfamide with formaldehyde solution in acidified water. When crystallized from acetone, it forms cubic crystals with a melting point of 255–260 °C.

Cutamesine (SA 4503) is a synthetic sigma receptor agonist which is selective for the σ1 receptor, a chaperone protein mainly found in the endoplasmic reticulum of cells in the central nervous system. These σ1 receptors play a key role in the modulation of Ca2+ release and apoptosis. Cutamesine's activation of the σ1 receptor is tied to a variety of physiological phenomena in the CNS, including activation of dopamine-releasing neurons and repression of the MAPK/ERK pathway.

Receptor theory is the application of receptor models to explain drug behavior. Pharmacological receptor models preceded accurate knowledge of receptors by many years. John Newport Langley and Paul Ehrlich introduced the concept that receptors can mediate drug action at the beginning of the 20th century. Alfred Joseph Clark was the first to quantify drug-induced biological responses. So far, nearly all of the quantitative theoretical modelling of receptor function has centred on ligand-gated ion channels and G protein-coupled receptors.

For related uses, see Rollback (disambiguation)

<span class="mw-page-title-main">Cariprazine</span> Atypical antipsychotic medicine

Cariprazine, sold under the brand names Vraylar and Reagila among others, is an atypical antipsychotic originated by Gedeon Richter, which is used in the treatment of schizophrenia, bipolar mania, bipolar depression, and major depressive disorder. It acts primarily as a D3 and D2 receptor partial agonist, with a preference for the D3 receptor. Cariprazine is also a partial agonist at the serotonin 5-HT1A receptor and acts as an antagonist at 5-HT2B and 5-HT2A receptors, with high selectivity for the D3 receptor. It is taken by mouth.

<span class="mw-page-title-main">Macitentan</span> Chemical compound

Macitentan, sold under the brand name Opsumit, is an endothelin receptor antagonist (ERA) developed by Actelion and approved for the treatment of pulmonary arterial hypertension (PAH). The other two ERAs marketed as of 2014 are bosentan and ambrisentan. Macitentan is a dual ERA, meaning that it acts as an antagonist of two endothelin (ET) receptor subtypes, ETA and ETB. However, macitentan has a 50-fold increased selectivity for the ETA subtype compared to the ETB subtype. The drug received approval from the U.S. Food and Drug Administration (FDA) on October 13, 2013.

<span class="mw-page-title-main">Biomolecular gradient</span>

A Biomolecular Gradient is established by a difference in the concentration of molecules in a biological system such as individual cells, groups of cells, or an entire organism. A biomolecular gradient can exist intracellularly or extracellularly. The purposes of such gradients in biological systems vary, but include chemotaxis and functions in development. These types of gradients play a role in many different types of signaling as well as recently being implicated in cancer metastasis.

References

  1. Bevan, Gwyn; Hood, Christopher (15 August 2006). "What's Measured Is What Matters: Targets and Gaming in the English Public Health Care System". Public Administration. 84 (3): 517–538. doi:10.1111/j.1467-9299.2006.00600.x . Retrieved 18 May 2021.
  2. Hardin, Garrett (September 1974). "Lifeboat ethics: the case against helping the poor". Psychology Today. Vol. 8. pp. 38–43. reprint
  3. Alan Peacock and Jack Wiseman , 1961, ISBN   0-87014-071-X
  4. Robert Higgs Crisis and Leviathan, OUP, 1987, ISBN   0-19-505900-X
  5. O'Reilly, Colin; Powell, Benjamin (2015). "War and the growth of government". European Journal of Political Economy. 40: 31–41. doi:10.1016/j.ejpoleco.2015.10.001.
  6. Tomasello, M. 1999. The Cultural Origins of Human Cognition. Cambridge, MA: Harvard University Press.
  7. Tennie, C.; Call, J.; Tomasello, M. (2009). "Ratcheting up the ratchet: on the evolution of cumulative culture". Phil. Trans. R. Soc. B. 364 (1528): 2405–2415. doi:10.1098/rstb.2009.0052. PMC   2865079 . PMID   19620111.
  8. Dyson, Steven; Gurdon, J.B (1998). "The Interpretation of Position in a Morphogen Gradient as Revealed by Occupancy of Activin Receptors". Cell. 93 (4): 557–568. doi: 10.1016/S0092-8674(00)81185-X . PMID   9604931. S2CID   2326620.
  9. "Mechanisms for standstill, rollback and listing of country specific reservations", Page 3 of note by MAI Negotiating Group chairman, OECD, 15 February 1996